Lyrica is currently approved in the United States for diabetic nerve pain, shingles-related discomfort, fibromyalgia and epileptic seizures.
Pfizer said the study involved 220 patients in 10 countries. Preliminary results showed the most common side effects were sleep troubles, dizziness, fatigue, dry mouth and blurred vision.
Read the Pfizer release on Lyrica.
Related Articles on Pain Medications:
New Spine Pain Management-Affiliated Center Opens in Florida
Dr. Otis Brawley Discusses Treatments for Tailbone Pain
Study: Acupuncture Has No Significant Impact on Back Pain, May Produce Negative Outcomes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
